Litcius/Paper detail

Development of a novel mammalian display system for selection of antibodies against membrane proteins

N.J. Robertson, Nancy López-Antón, Shalom A. Gurjar, Hena Khalique, Zainab A. Khalaf, Siobhan Clerkin, Vaughan R. Leydon, Richard Parker-Manuel, Alexander Raeside, Tom Payne, Tim D. Jones, Leonard W. Seymour, Ryan Cawood

2020Journal of Biological Chemistry31 citationsDOIOpen Access PDF

Abstract

Reliable, specific polyclonal and monoclonal antibodies are important tools in research and medicine. However, the discovery of antibodies against their targets in their native forms is difficult. Here, we present a novel method for discovery of antibodies against membrane proteins in their native configuration in mammalian cells. The method involves the co-expression of an antibody library in a population of mammalian cells that express the target polypeptide within a natural membrane environment on the cell surface. Cells that secrete a single-chain fragment variable (scFv) that binds to the target membrane protein thereby become self-labeled, enabling enrichment and isolation by magnetic sorting and FRET-based flow sorting. Library sizes of up to 109 variants can be screened, thus allowing campaigns of naïve scFv libraries to be selected against membrane protein antigens in a Chinese hamster ovary cell system. We validate this method by screening a synthetic naïve human scFv library against Chinese hamster ovary cells expressing the oncogenic target epithelial cell adhesion molecule and identify a panel of three novel binders to this membrane protein, one with a dissociation constant (KD) as low as 0.8 nm. We further demonstrate that the identified antibodies have utility for killing epithelial cell adhesion molecule–positive cells when used as a targeting domain on chimeric antigen receptor T cells. Thus, we provide a new tool for identifying novel antibodies that act against membrane proteins, which could catalyze the discovery of new candidates for antibody-based therapies. Reliable, specific polyclonal and monoclonal antibodies are important tools in research and medicine. However, the discovery of antibodies against their targets in their native forms is difficult. Here, we present a novel method for discovery of antibodies against membrane proteins in their native configuration in mammalian cells. The method involves the co-expression of an antibody library in a population of mammalian cells that express the target polypeptide within a natural membrane environment on the cell surface. Cells that secrete a single-chain fragment variable (scFv) that binds to the target membrane protein thereby become self-labeled, enabling enrichment and isolation by magnetic sorting and FRET-based flow sorting. Library sizes of up to 109 variants can be screened, thus allowing campaigns of naïve scFv libraries to be selected against membrane protein antigens in a Chinese hamster ovary cell system. We validate this method by screening a synthetic naïve human scFv library against Chinese hamster ovary cells expressing the oncogenic target epithelial cell adhesion molecule and identify a panel of three novel binders to this membrane protein, one with a dissociation constant (KD) as low as 0.8 nm. We further demonstrate that the identified antibodies have utility for killing epithelial cell adhesion molecule–positive cells when used as a targeting domain on chimeric antigen receptor T cells. Thus, we provide a new tool for identifying novel antibodies that act against membrane proteins, which could catalyze the discovery of new candidates for antibody-based therapies. Mammalian display was originally conceived for affinity maturation of single-chain variable fragments (scFv) expressed on the surface of human cells (1Ho M. Nagata S. Pastan I. Isolation of anti-CD22 Fv with high affinity by Fv display on human cells.Proc. Natl. Acad. Sci. U.S.A. 2006; 103 (16763048): 9637-964210.1073/pnas.0603653103Crossref PubMed Scopus (133) Google Scholar) and has been further developed for screening full-length antibody cell surface–expressed libraries (2Akamatsu Y. Pakabunto K. Xu Z. Zhang Y. Tsurushita N. Whole IgG surface display on mammalian cells: application to isolation of neutralizing chicken monoclonal anti-IL-12 antibodies.J. Immunol. Methods. 2007; 327 (17719061): 40-5210.1016/j.jim.2007.07.007Crossref PubMed Scopus (54) Google Scholar, 3Zhou C. Jacobsen F.W. Cai L. Chen Q. Shen W.D. Development of a novel mammalian cell surface antibody display platform.mAbs. 2010; 2 (20716968): 508-51810.4161/mabs.2.5.12970Crossref PubMed Scopus (68) Google Scholar). The use of mammalian cell display (4Zhou Y. Chen Z.-R. Li C.-Z. He W. Liu S. Jiang S. Ma W.-L. Tan W. Zhou C. A novel strategy for rapid construction of libraries of full-length antibodies highly expressed on mammalian cell surfaces.Acta Biochim. Biophys. Sinica. 2010; 42: 575-58410.1093/abbs/gmq055Crossref PubMed Scopus (11) Google Scholar) has some important advantages over other display systems (e.g. phage/yeast), in particular in relation to the manufacturability of the identified antibodies; in mammalian display, antibodies are produced using the endogenous eukaryotic secretion machinery enabling correct folding and biophysical properties and are therefore more likely to be compatible with mammalian cell production systems. However, a disadvantage of using mammalian display is that only a relatively small library size (usually up to 107) can be interrogated. The library sizes that are available for mammalian systems are typically limited by low transfection efficiency, although recent advances have improved this, for example by using CRISPR–Cas9 integration methods (5Parola C. Neumeier D. Friedensohn S. Csepregi L. Di Tacchio M. Mason D.M. Reddy S.T. Antibody discovery and engineering by enhanced CRISPR–Cas9 integration of variable gene cassette libraries in mammalian cells.mAbs. 2019; 11 (31478465): 1367-138010.1080/19420862.2019.1662691Crossref PubMed Scopus (10) Google Scholar, 6Parthiban K. Perera R.L. Sattar M. Huang Y. Mayle S. Masters E. Griffiths D. Surade S. Leah R. Dyson M.R. McCafferty J. A comprehensive search of functional sequence space using large mammalian display libraries created by gene editing.mAbs. 2019; 11 (31107136): 884-89810.1080/19420862.2019.1618673Crossref PubMed Scopus (22) Google Scholar). Alternatively, library size can be effectively expanded by first utilizing phage display (7Frenzel A. Schirrmann T. Hust M. Phage display-derived human antibodies in clinical development and therapy.mAbs. 2016; 8 (27416017): 1177-119410.1080/19420862.2016.1212149Crossref PubMed Scopus (198) Google Scholar, 8Frenzel A. Kügler J. Helmsing S. Meier D. Schirrmann T. Hust M. Dübel S. Designing human antibodies by phage display.Transfus. Med. Hemother. 2017; 44 (29070976): 312-31810.1159/000479633Crossref PubMed Scopus (58) Google Scholar) to screen much larger naïve libraries before converting to mammalian cell display after one or two rounds of selection or by using libraries derived from immunized animals, in which initial antibody selection and maturation has occurred in vivo (6Parthiban K. Perera R.L. Sattar M. Huang Y. Mayle S. Masters E. Griffiths D. Surade S. Leah R. Dyson M.R. McCafferty J. A comprehensive search of functional sequence space using large mammalian display libraries created by gene editing.mAbs. 2019; 11 (31107136): 884-89810.1080/19420862.2019.1618673Crossref PubMed Scopus (22) Google Scholar). With current mammalian display methods, the cells displaying the antibodies are incubated with the target antigen, which must be available in a soluble format and used either free in solution or bound to paramagnetic beads (1Ho M. Nagata S. Pastan I. Isolation of anti-CD22 Fv with high affinity by Fv display on human cells.Proc. Natl. Acad. Sci. U.S.A. 2006; 103 (16763048): 9637-964210.1073/pnas.0603653103Crossref PubMed Scopus (133) Google Scholar, 9Beerli R.R. Bauer M. Buser R.B. Gwerder M. Muntwiler S. Maurer P. Saudan P. Bachmann M.F. Isolation of human monoclonal antibodies by mammalian cell display.Proc. Natl. Acad. Sci. U.S.A. 2008; 105 (18812621): 14336-1434110.1073/pnas.0805942105Crossref PubMed Scopus (138) Google Scholar, 10Bowers P.M. Horlick R.A. Kehry M.R. Neben T.Y. Tomlinson G.L. Altobell L. Zhang X. Macomber J.L. Krapf I.P. Wu B.F. McConnell A.D. Chau B. Berkebile A.D. Hare E. Verdino P. et al.Mammalian cell display for the discovery and optimization of antibody therapeutics.Methods. 2014; 65 (23792919): 44-5610.1016/j.ymeth.2013.06.010Crossref PubMed Scopus (47) Google Scholar). The latter system can be in antigen thus allowing for the selection of cells that express low affinity antibodies E. K. Meier M. L. C. M. A. M. L. and screening of a high antibody 2014; 65 PubMed Scopus Google Scholar). antigen must be to cells in solution or to the target is typically to proteins or protein that are soluble and relatively identifying antibodies to membrane proteins methods can be used with phage display to for phage that to membrane proteins S. M.R. T. R. M. application of cell for isolation of phage antibody fragments specific to 2019; PubMed Scopus Google Scholar, S. Zhang S. M. N. membrane proteins for antibody discovery using phage 2016; PubMed Scopus Google the phage and this can thereby the of binders for for phage against cell surface The to screen large naïve libraries within a mammalian a by the and of identified antibodies with mammalian cell the to use two discovery important targets are membrane proteins, the to screen against a membrane antigen in native configuration within a membrane environment that only are thus a of identifying functional provide a mammalian display with we a method by which we large antibody libraries with of and use to cells that have been to express the target membrane much larger library sizes to be with methods and is only limited by the of cells that can be in the strategy in cells expressing the target antigen on their cell surface and a from the high scFv cells that express an scFv of the target thus allowing to be and have identified co-expression of and antigen in a cell as a method to screen for for example in a display system X. Y. Liu Y. Chen Y. N. Jiang S. Zhang S. Wu Q. Li T. Zhang Y. Zhou B. J. Li D. scFv antibodies against by co-expression of antigen and antibody in the display Immunol. 2016; PubMed Scopus Google Scholar) and for affinity maturation in mammalian cells A. M. S. D. K. T. M. antibody affinity maturation system utilizing mammalian cell as 2019; PubMed Scopus Google Scholar). However, we for the first the screening of a large naïve scFv library in a mammalian system and identify binders to a membrane protein antigen on the cell surface. We present the isolation of cells that secrete that to the membrane protein a and has been identified as a antigen, of in epithelial A. K. M. I. in clinical J. 2010; PubMed Scopus Google Scholar). this has been to to other cell cell and M. P.M. cell adhesion more a and adhesion J. 2007; PubMed Scopus Google Scholar, L. Y. Liu S. Z. Z. J. of in and J. Med. Google Scholar). cells by magnetic cell sorting a method used to and specific cell X. Li Z. Li Z. Chen C. Liu Isolation and enrichment of cells using and PubMed Scopus (22) Google Scholar). was by to a cell population that in the of and has been used to within the of flow and thereby the of in large cell C. J. D. M. R. J. M. A flow to identify and in 2010; PubMed Scopus Google Scholar). of the of the and a cells expressing specific antigen to be from that bound endogenous cell surface this cell screened, and to the of novel that bound to the protein on the cell surface. We further the utility of the identified for the targeting of cells to cells. cells expressing human a by of a cell with a the gene and a The of cells and cells that the of by surface cells by and expanded cell for and a was identified for use in further and cells for by flow using an antibody The of cells for to cells and cells of cells for as with that some of was present in the cells with a a scFv with a for either in the or of the cells with an which although the cells in the of a in was in the of A large of expressing cells 109 was with a an scFv library a of of The scFv library used was by of antibody fragments the human of and of the and of and of the synthetic from to is therefore a synthetic of the human naïve and a of and within the in of sequence and The of the library was and was to variants by by limited of the used for for the cells expressing the scFv library cells for with to and to three rounds of enrichment by using an system the cells incubated with antibodies to with and on magnetic The cell was from the magnetic and to for before and selection the first the cells from a cell population of 109 cells with an of cells. allowing the cells to cells and selected as before with an of cells. the of cells and selected with an of cells. three rounds of the cell was this the cell was likely to three the population that by scFv cells by by cells and cells by specific for endogenous cell surface proteins to for cells with as the cells by three rounds of with an of cells expressing the cell used for library Thus, when the cell was in the of to target the cells the specific and by the cells. cells with the that could be from the a was to the cell population that in the of a and an the and have to be in to a specific antigen are more likely to a this method of cells specific antigen from that endogenous cell surface The from the magnetic was to two rounds of on an cell by the cells a in the by of the to the to the target The cell was with cells to the of as cells with cells and for in The was created in a and of cells the first cells a and of cells was cells a using in the of cells in cells in using a more and expanded over a of was on a system to a The on and in in that sorting and 107) for their to with in the and of antigen by and cells with an by flow selected on the of a on cells with further using a from against target antigen expressing cells and cells a R.A. et in after of 2006; PubMed Scopus Google selected of their secretion of specific to 11 to cells with to cells and therefore one to cells and cells and was therefore specific for a cell surface the more variable or an selected on the of displaying some of and cells the of the of the variable domain from the selected binders and a we identified sequence by and of which in more one with the sequence of in selected and and a sequence as scFv and full-length and cells to express The from the cells against cells or cells to their and to to cells when as scFv and the in either or to when as scFv in the format with was the initial and and this sequence been selected for was present in the The three either as scFv or to the cells with the in The a protein A affinity and by and and The antibodies and only of IgG variants to and cells in a to the on cells The IgG derived from the only the therefore an could be However, the derived from and of and on a of and on a protein A surface using human domain of as of and The constant of 105 was for the other two the dissociation three antibodies by of the antibody by and in a new We the by of the soluble domain with the and as the this we only of the for only of the for and for that only a of the domain or antibody was on the or binds a or this be to a of the domain on the surface. However, for and could be of and The large the two for to be by a large in the from 103 to using mammalian display we have an specific antibody with an The the and be to the of the two as the high of the soluble domain of used in an with the of cell surface on the cells used in the the in and targeting of cells with to express an chimeric antigen T cell receptor R.A. et in after of 2006; PubMed Scopus Google cells with panel of three cell cell and the cell used for antibody used as targets and cells and T cells derived from human cells used as cells. cells by of either cells or T cells derived from human was to a with scFv to a by a domain and a T cells derived from human expanded for before cells with the and an scFv The antigen of the cells was in a with and cell cells a in the of and by and and cell and by and only with target cells and with cells. The cells display was to the with T cells in the against cells a of We further the target cell killing in of and cells in by cell a of cell the of and cells for with cells and of cells was within cell was either with cells and in cells or with cells with either cell the scFv against and cells using cells as cells with the and as to with target cells. cells incubated with and cells for before cell the a of in the of and target cells with cells The of be to the of a of in to affinity to that and cells are and and and that is more with has identified against using a naïve library that the natural naïve human was in a mammalian cell with for initial in other systems. has the to be as a novel to identifying new antibodies against other membrane proteins in their native environment in and in a mammalian cell system used for antibody and thus the of the antibodies with systems. The use of of large of mammalian and their for of L. A. B. of cell for the of proteins and other J. Sci. 2010; Google Scholar) was to that the of the library was expressed for of The of the the of cells by or more to a and using a of in of cells with cells with one integration cells with two integration and cells with more two integration the current selection in this we cells with more one integration in other campaigns we have binders from cells with two integration of the correct which to the of the although a with more two integration be more the of more two integration is relatively we this to be for selection we are to the to the that the the of integration the of cells with integration and the of cells that can be for the first selection this the initial selection was with 109 and we that this can be to with the of further The of this in the for antibody by one cell binds to the surface of and scFv specific for cell surface proteins or We that is the of cells in the initial population of cells is the of the as the of cells we two to against the use of cells expressing antigen only to with as a method for the selected after a of FRET-based cell an scFv that to to the cell to an in the of cell surface one of the an scFv that either to or which that been effectively the method to the selection of binders to have been only and is for for the of selection of cells an the of the and using a more strategy the of the current of selection of cells is The the use of a antibody that was to the this be in in which the target is However, the of an has been used as an further we was the selection of three antibodies that to to cells with against cells one antibody in particular was selected antibodies as bound to cells when expressed as The for this are the of initial cells selected was low M. a for of receptor 2014; PubMed Scopus Google this was by low of which was as low as in cell and the of cells the of cells and the of selected in library and are to the of the current library a of the of was to be in cell to cells with that 109 cells one or two integration of libraries of 109 is this is as large as some phage display libraries that have been created E. L. P. N. A. B. M. C. L. R. for antibody PubMed Scopus Google Scholar, J. S. C. A. S. Bauer M. S. Y. J. A. S. M. a synthetic library for sequence and in mammalian PubMed Scopus Google Scholar, T. I. D. K. R. T. M. D. J. Y. M. D. K. S. J. et synthetic human antibody library on with biophysical PubMed Scopus Google has been to libraries that a high of functional that are to sequence that be we to a specific with We that this system has a particular utility for identifying scFv binders against membrane proteins for cell this we the three binders as which T cells from human and cells. We to demonstrate that the two scFv and of of the T cells and against cells. cells in the of an cell and although the was in this to the of the the by a configuration with that of a soluble or the affinity of this we that the novel display method is the first enabling the discovery of target specific from an library in a mammalian cell system. the to identify novel antibodies against membrane proteins in a with properties for use either in a cell or as a A was to of The a with that the of the as as a gene an of the allowing of the target protein by A gene was the gene and by an sequence to selection the was of the the scFv library a was to of scFv The has a that the of the by the The was derived from sequence from The scFv library was by functional human and that been and by to human and by A sequence was of the and a The from the human by and which to the and that been from an and with by to the of the to of three and to the of We are to this scFv library to for a to a Library by using on an using the M. a for of receptor 2014; PubMed Scopus Google Scholar) J. Ma N. an variable domain sequence PubMed Scopus Google Scholar) was used to antibody-based on The M. D. a for cell PubMed Scopus Google was used to and the of the within the scFv library population was and produced using and for Google Scholar, a for sequence 2017; PubMed Scopus Google Scholar). cells and expanded for in with in in a A cell expressing full-length was by of a of with a the gene and a of after the was and the cells further in for and of the cell by cell surface with an antibody and sorting on a The cells cell The on and for by flow after and was for further on cells of in with in a cells in with in a cells in with in a cells in 2 and in a The scFv synthetic library was in cells. 2 cells before transfection in The cells with of library and and of transfection The by for and The of the was by and the on cells of was by flow The of the library was by using the for the 109 cells to a cell of with the scFv library was with to the was and the cells incubated in with before magnetic selection was using an to the of with and 2 was used the the first of 109 cells with the library with of antibody for by with of for and cell selection using the the was with of for the of cells. the of cells was to for before with for a further The was and cells incubated to the cells with and in to either the from the of selection or the from the first cells for and in and The cell was incubated for in a for cells with to of as as the cell to in on cells was using an cell with the first of cells with 2 and in the with antibody and antibody for cells with antibody the The cells with and in the for and sorting. cells on for a cell was The was on a the of the first cells and to and A of selection was the that was used the and the cell was cells in The cells expanded and with after 2 by to after using an flow with two of and to an The in and from The cell and with before for with the antibody in The cells with the before The cells on and by on the cells using from cells by and either as scFv the as or as a the and expressed from gene on the which an was and used to cells using to the in a of either for or for of A was using of to the antibodies using and by nm. The from either scFv or IgG incubated with either cells or cells for in a and with before and with either or for the cells a further two before on an flow the to in of antibodies derived from the and to either cells or cells and incubated for in a and with before and with for the cells a further two before on an flow The cells on and by on the cells using The affinity of IgG antibody variants for the was by surface on a of the antibody variants was the surface of a protein A The in and was for and by a dissociation with the using The was by the surface of a by an The in and antibodies for and by a dissociation with the using from was from the and by as by the of T cells from cells using a T cell isolation T cells in with 2 and T cells in and a 2 the in and and to the of was and with the cells to a and in the cells up to a cells derived from two and incubated with either or cells the cell and by flow to using an antibody and was by of using a of and cells incubated with cells of was in using The cells incubated for before cells and cell was for a of cells incubated in 2 C. Neumeier D. Friedensohn S. Csepregi L. Di Tacchio M. Mason D.M. Reddy S.T. Antibody discovery and engineering by enhanced CRISPR–Cas9 integration of variable gene cassette libraries in mammalian cells.mAbs. 2019; 11 (31478465): 1367-138010.1080/19420862.2019.1662691Crossref PubMed Scopus (10) Google with in a the of was to and on the cells to a the cells expanded by a of C. Neumeier D. Friedensohn S. Csepregi L. Di Tacchio M. Mason D.M. Reddy S.T. Antibody discovery and engineering by enhanced CRISPR–Cas9 integration of variable gene cassette libraries in mammalian cells.mAbs. 2019; 11 (31478465): 1367-138010.1080/19420862.2019.1662691Crossref PubMed Scopus (10) Google and of a The cells expanded in cell and cells in and to a of K. Perera R.L. Sattar M. Huang Y. Mayle S. Masters E. Griffiths D. Surade S. Leah R. Dyson M.R. McCafferty J. A comprehensive search of functional sequence space using large mammalian display libraries created by gene editing.mAbs. 2019; 11 (31107136): 884-89810.1080/19420862.2019.1618673Crossref PubMed Scopus (22) Google cells with target cell a of for The cells with and with for The cells three with by of on an flow with are within the We the for with the with single-chain fragment variable Chinese hamster ovary epithelial cell adhesion molecule chimeric antigen receptor T cell magnetic cell sorting of cell surface

Topics & Concepts

Chinese hamster ovary cellMonoclonal antibodyAntibodyPolyclonal antibodiesBiologyCell sortingMembrane proteinAntigenMolecular biologyCell biologySingle-chain variable fragmentChemistryFlow cytometryBiochemistryMembraneReceptorImmunologyMonoclonal and Polyclonal Antibodies ResearchCAR-T cell therapy researchViral Infectious Diseases and Gene Expression in Insects
Development of a novel mammalian display system for selection of antibodies against membrane proteins | Litcius